Malaria is one of the most important tropical diseases; the use of amodiaquine as a current chemotherapy in the treatment of malaria has shown some problems such as hepatotoxicity and agranulocytosis. In this work we present the rational design, synthesis, and biological evaluation (antimalarial activity, cytotoxicity and genotoxicity) of four new fluoroamodiaquine analogues. The results showed significant correlation between MolDock score and IC 50 values. The molecules 7b and c were the most active of the planned compounds, with lower IC 50 against Plasmodium falciparum W2 strain (0.9 and 0.8 µM, respectively) and an excellent cytotoxicity profile. The present study revealed no mutagenicity or genotoxicity for the analogues. Confirming our docking results, the molecular dynamics showed that compound 7b remains stably bound to the heme group by means of π-stacking interactions between quinoline and the porphyrin ring. Based on these findings, this study may prove to be an efficient approach for the rational design of hemozoin inhibiting compounds to treat malaria.Key words docking; molecular dynamics; molecular modeling; antimalarial Malaria is one of the most important tropical diseases, affecting 97 countries. It is an infectious disease caused by five species of Plasmodium genus protozoa, from which the P. falciparum is the most lethal in humans. There were approximately 198 million cases of malaria reported in 2013, and an estimated number of 584000 deaths, mainly in African subSaharan countries.1)The chemotherapy combination of artesunate and amodiaquine (ASAQ) is currently the treatment recommended by WHO. However, recent reports show that P. falciparum has become resistant to these chemotherapeutic agents. In addition, the use of amodiaquine (AQ) (Fig. 1) has shown some problems such as hepatotoxicity and agranulocytosis.2-4) This is a result of the biotransformation that occurs in the liver by CYP450 enzymes, which generates a reative quinoneimine metabolite, the amodiaquine quinone imine (AQQI) 5) (Fig. 1). This metabolite binds irreversibly to cellular macromolecules, leading to cell death by oxidation and, probably, to direct toxicity as well as immune-mediated hypersensitivity reactions.6,7) The mechanism of action of AQ and other 4-aminoquinolines is based on the inhibition of the parasite's mechanism of detoxification of heme, namely, the inclusion of free heme into hemozoin. By doing so, AQ increases the concentration of free heme inside the host cell acidic digestive vacuole, killing the parasite by oxidative stress. [8][9][10][11][12][13] The design of new amodiaquine derivatives with reduced toxicity and increased activity is a current matter of study.14-17) It's already well established in the literature that the fluorine insertion in this series is favorable to reduce the hepatotoxicity, by forming new compounds that are more resistant to oxidation and hence less likely to form toxic quinone imine metabolites in vivo. 2,3,17,18) O'Neill et al. demonstrated that the 4′-hydroxyl group could b...